GP6 and central nervous system cancer: An analysis of “Canonical Pathways” (well established and manually curated metabolic and signalling pathways) potentially influenced by DE genes identified glycoprotein VI (GP6) signalling and glioma invasiveness signalling as significantly downregulated (Z-score < 2) in patient fibroblasts compared to controls.